In Hypertension (October), Egan et al 1 provide a new definition of treatment-resistant hypertension and compare treatment with ≤2 versus ≥3 classes of antihypertensive agents for uncontrolled and controlled hypertensive individuals. We focus on the uncontrolled group in which blood pressure (BP) was lower with fewer drugs.
1
and we find that PWV was higher in the group taking ≥3 classes of antihypertensive drugs, an association that was sustained when we adjusted age, education, sex, ethnicity, body mass index, diabetes mellitus, and total cholesterol: categorical regression coefficient (b=1.63; SE=0.055; P<0.01). We replicated these findings when the Egan et al 1 requirement that a diuretic be included in drug combinations was dropped, ≤2 (n=155) ≥3 (n=66).
We confirm Egan et al 1 with our small sample and data on PWV. These data reinforce the concern for effective management of hypertension in polypharmacy, including literature-based choice of drugs and improved patient education and adherence. 1, 5 This analysis was approved by the University of Maine Institutional Review Board. 
